Rohit Agarwal, . Designation Director at EXPERGEN PHARMACEUTICALS PRIVATE LIMITED.
Rupa Sayiour, . Designation Director at EXPERGEN PHARMACEUTICALS PRIVATE LIMITED.
Vijay Lahoti, . Designation Director at EXPERGEN PHARMACEUTICALS PRIVATE LIMITED.
Located at MULUND WEST, MUMBAI, Maharashtra. .

Searching for a company ?

Find all the information about a company you are looking for!

EXPERGEN PHARMACEUTICALS PRIVATE LIMITED

About Expergen Pharmaceuticals Private Limited
Expergen Pharmaceuticals Private Limited was registered at Registrar of Companies ROC Mumbai on 12 February, 2011 and is categorised as Company limited by shares and an Non-government company.
Expergen Pharmaceuticals Private Limited's Corporate Identification Number (CIN) is U74120MH2011PTC213351 and Registeration Number is 213351.

Expergen Pharmaceuticals Private Limited registered address on file is MULUND WEST, MUMBAI - 400078, Maharashtra, India.

Expergen Pharmaceuticals Private Limited currently have 2 Active Directors / Partners: Rupa Sayiour, Vijay Lahoti, and there are no other Active Directors / Partners in the company except these 2 officials.

Expergen Pharmaceuticals Private Limited is involved in Activity and currently company is in Active Status.

Company Name EXPERGEN PHARMACEUTICALS PRIVATE LIMITED
CIN U74120MH2011PTC213351
Registration Date 12 February, 2011
Registeration No. 213351
RoC ROC Mumbai
State Maharashtra
Registered Address MULUND WEST, MUMBAI - 400078, Maharashtra, India
Category Company limited by shares
Sub Category Non-government company
Authorised Capital Rs 1400000 INR
PaidUp Capital Rs 800000 INR
Company Class Private
Last Annual General Meeting Date 31 December, 2020
Date of Balance Sheet 31 March, 2020
Is Company Listed Not Listed
Company Status Active
Active Directors
Director Name
Rupa Sayiour
Vijay Lahoti
Resigned Directors
Director Name
Rohit Agarwal
Index of Charges
Asset Name Amount Creation Date Modification Date Status
No Charges found

Are you owner of this company?

Problem with this data ?

Click here